申请人:GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD
公开号:US20170174703A1
公开(公告)日:2017-06-22
Disclosed are quinoline derivatives as hedgehog pathway inhibitors, especially as SMO inhibitors. Compounds of the present invention can be used in treating diseases relating to hedgehog pathway including cancer.